IL285619A - Universal donor stem cells and related methods - Google Patents

Universal donor stem cells and related methods

Info

Publication number
IL285619A
IL285619A IL285619A IL28561921A IL285619A IL 285619 A IL285619 A IL 285619A IL 285619 A IL285619 A IL 285619A IL 28561921 A IL28561921 A IL 28561921A IL 285619 A IL285619 A IL 285619A
Authority
IL
Israel
Prior art keywords
stem cells
related methods
universal donor
donor stem
universal
Prior art date
Application number
IL285619A
Other languages
English (en)
Hebrew (he)
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of IL285619A publication Critical patent/IL285619A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1114—T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL285619A 2019-02-15 2021-08-15 Universal donor stem cells and related methods IL285619A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201916277913A 2019-02-15 2019-02-15
US201916596697A 2019-10-08 2019-10-08
PCT/US2020/018467 WO2020168317A2 (en) 2019-02-15 2020-02-16 Universal donor stem cells and related methods

Publications (1)

Publication Number Publication Date
IL285619A true IL285619A (en) 2021-09-30

Family

ID=72045137

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285619A IL285619A (en) 2019-02-15 2021-08-15 Universal donor stem cells and related methods

Country Status (11)

Country Link
EP (1) EP3924375A4 (es)
JP (1) JP2022526218A (es)
KR (1) KR20210128440A (es)
CN (1) CN113906048A (es)
AU (1) AU2020223192A1 (es)
BR (1) BR112021016178A2 (es)
CA (1) CA3130398A1 (es)
IL (1) IL285619A (es)
MX (1) MX2021009842A (es)
SG (1) SG11202108891QA (es)
WO (1) WO2020168317A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021231712A1 (en) * 2020-05-15 2021-11-18 Rxcell Inc. Hypoimmunogenic cells and uses thereof in immune responses
CN114276995A (zh) * 2020-09-28 2022-04-05 未来智人再生医学研究院(广州)有限公司 一种表达ctla-4阻遏分子的多能干细胞及其衍生物
CN114525257A (zh) * 2020-10-30 2022-05-24 未来智人再生医学研究院(广州)有限公司 一种表达Tim-3阻断物的多能干细胞或其衍生物及应用
CN114525256A (zh) * 2020-10-30 2022-05-24 未来智人再生医学研究院(广州)有限公司 一种表达Siglec-15阻断物的多能干细胞或其衍生物及应用
CN114457021A (zh) * 2020-10-30 2022-05-10 未来智人再生医学研究院(广州)有限公司 一种表达cd47抗体的多能干细胞及其衍生物与应用
EP4251741A1 (en) 2020-11-30 2023-10-04 CRISPR Therapeutics AG Gene-edited natural killer cells
CR20230303A (es) * 2020-12-11 2023-09-01 Intellia Therapeutics Inc Composiciones y métodos para reducir el mhc de clase ii en una célula
AU2021410751A1 (en) * 2020-12-23 2023-07-13 Intellia Therapeutics, Inc. Compositions and methods for genetically modifying ciita in a cell
MX2023006207A (es) 2020-12-31 2023-08-09 Sana Biotechnology Inc Métodos y composiciones para modular la actividad de linfocitos t con receptores de antígenos quiméricos (t-car).
AU2022283291A1 (en) 2021-05-27 2023-11-02 Sana Biotechnology, Inc. Hypoimmunogenic cells comprising engineered hla-e or hla-g
MX2024001443A (es) 2021-08-11 2024-05-15 Sana Biotechnology Inc Sistemas inducibles para alterar la expresión génica en células hipoinmunógenas.
KR20240137574A (ko) 2021-12-23 2024-09-20 사나 바이오테크놀로지, 인크. 자가면역 질환 치료를 위한 키메라 항원 수용체[chimeric antigen receptor, car] t 세포 및 관련 방법
WO2023154578A1 (en) 2022-02-14 2023-08-17 Sana Biotechnology, Inc. Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
WO2023191063A1 (ja) * 2022-04-01 2023-10-05 株式会社Logomix 遺伝子工学、細胞工学、および細胞医薬に適した細胞およびその製造方法
WO2024003349A1 (en) 2022-07-01 2024-01-04 Novo Nordisk A/S Enhancing neuronal differentiation of ventral midbrain neural progenitor cells
CN118406681A (zh) * 2023-01-30 2024-07-30 南京北恒生物科技有限公司 用于同种异体移植的组合物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016261600B2 (en) * 2015-05-08 2021-09-23 President And Fellows Of Harvard College Universal donor stem cells and related methods
ES2953925T3 (es) * 2015-11-04 2023-11-17 Fate Therapeutics Inc Ingeniería genómica de células pluripotentes
JP2020505025A (ja) * 2017-01-13 2020-02-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 免疫工学的な改変をした多能性細胞

Also Published As

Publication number Publication date
CN113906048A (zh) 2022-01-07
WO2020168317A8 (en) 2021-02-25
SG11202108891QA (en) 2021-09-29
WO2020168317A2 (en) 2020-08-20
BR112021016178A2 (pt) 2021-11-03
CA3130398A1 (en) 2020-08-20
EP3924375A2 (en) 2021-12-22
EP3924375A4 (en) 2023-03-22
KR20210128440A (ko) 2021-10-26
MX2021009842A (es) 2021-12-10
WO2020168317A3 (en) 2020-10-29
AU2020223192A1 (en) 2021-09-09
JP2022526218A (ja) 2022-05-24

Similar Documents

Publication Publication Date Title
IL285619A (en) Universal donor stem cells and related methods
AU2021221859A1 (en) Universal donor stem cells and related methods
EP3652304A4 (en) UNIVERSAL DONOR CELLS AND RELATED PROCESSES
EP3423564A4 (en) MICROGLIAL CELLS DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF PREPARATION AND USE THEREOF
IL281280A (en) Universal donor cells
IL276523A (en) Modified pluripotent stem cells and methods of preparation and use
IL283169A (en) CRISPR-CAS12J enzyme and system
EP3707240A4 (en) STEM CELLS AND BONE REGENERATION DEVICES
EP3334820A4 (en) Induced extended pluripotent stem cells, methods of making and using
IL281171A (en) Cellulose-synthase-like enzymes and their uses
EP3591741A4 (en) SECONDARY BATTERY AND SECONDARY BATTERY CONTROL METHOD
EP3336176A4 (en) IMPROVED ANNEXED STRAIN CELLS FROM HORIZONTAL TISSUE, MANUFACTURING METHOD AND USE THEREOF
IL291044A (en) Universal donor cells
IL290504A (en) Universal donor cells
EP3865571A4 (en) MESENCHYMATOUS STEM CELLS DERIVED FROM THE SYNOVIAL AND THEIR USE
GB201701509D0 (en) Pluripotenet stem cells
EP4041255A4 (en) MODIFIED STEM CELLS AND THEIR USE
IL277878A (en) Preparations and methods for stem cell transplantation
EP3288570A4 (en) Modified stem cells and uses thereof
EP3426268A4 (en) PANCREATIC STEM CELLS AND USES THEREOF
GB201805287D0 (en) Haematoietic stem cell treatment
PL3833756T3 (pl) Enzymy epimerazy i ich zastosowanie
EP3680324A4 (en) STEM CELLS FROM A YOUNG PIG AND METHOD OF MANUFACTURING THEREFORE
EP3866816A4 (en) EXOSOMES FROM MESENCHYMATOUS STEM CELLS AND METHODS
IL267628A (en) Splitting and harvesting formula for obtaining single pluripotent human stem cells